Gain Therapeutics GANX Bounces Back Testing Key Resistance at 187 California BanCorp BCAL Gains Ground Nears Key Resistance Level Xilio Therapeutics XLO Shows Resilience with 191 Gain Approaching Key Resistance HCM III Acquisition Corp HCMA Holds Near Support Amid Low Volatility First Guaranty Bancshares Preferred FGBIP Edges Lower as Consolidation Continues